Biotechnology

Automation software developers Celltrio and Biosero will integrate Biosero’s Green Button Go Automation Scheduling Software with Celltrio’s RoboCell Automation Platform to accelerate cell line culturing and harvesting processes, including cryogenic storage, into a new end-to-end system. The aim is that Green Button Go will accelerate the cell culture and harvesting process, by as much as […]

Thermo Fisher Scientific has launched the Thermo Scientific Herasafe 2025 BSC, for the safe sample handling needs of life science applications. It is a Class II Biological Safety Cabinet (BSC) designed to meet the sample and user protection requirements of bioprocessing, clinical diagnostic and biopharmaceutical laboratories. According to Thermo Fisher Scientific, the product uses technology […]

Resilience in pharma and biotech supply chains is essential for the roll out of the Covid-19 vaccine, says Karl Lauri, ERP/MRP software manufacturer and distributor MRPeasy.com.  While the pandemic has highlighted the strength of the UK’s pharmaceutical and biotechnology sector, it has also shed light on the vulnerabilities of intricate, geographically extended and time-critical supply chains which needs to be prioritised. An efficient ERP/MRP ‘backbone’ will […]

WuXi AppTec, provider of R&D and manufacturing-enabling services in the pharmaceutical, biotechnology and medical device industries, has completed the acquisition of OXGENE, a UK-based contract research and development organisation that designs and develops scalable gene therapy technologies. This acquisition enables WuXi AppTec to offer its customers end-to-end support in the creation and development of cell […]

Last year IONTAS, a biotechnology company focused on antibody discovery and development, entered into a licensing agreement with Bristol Myers Squibb for its proprietary mammalian display. John McCafferty, nuclease directed mammalian display inventor and co-inventor of antibody phage display, told Lu Rahman about this breakthrough work. The company operates as a single group comprised of […]

Today’s episode is titled The potential of metabolomics & COVID-19 Vaccine Development, and covers 2 articles taken from the most recent Fall issue of DDW. These articles are titled: Why metabolomics has the potential to transform diagnosis and treatment. & COVID-19 Vaccine Development: dethroning evil King Coronavirus These articles were firstly based on an interview with […]

Mark Egerton, Chief Executive Officer, Quotient Sciences, spoke to Lu Rahman about the company’s acquisition of Arcinova and what it means for the drug discovery sector. Quotient Sciences, the drug development and manufacturing accelerator, recently acquired Arcinova, the UK-based multiservice contract development and manufacturing organisation (CDMO). Boasting over 40 years of experience and 160 employees, Arcinova […]

ERS Genomics and G+FLAS Life Sciences, a biotechnology company developing research tools and reagents associated with CRISPR technology, have announced a non-exclusive license agreement granting G+FLAS access to ERS Genomics’ CRISPR/Cas9 patent portfolio. G+FLAS supports research organisations by providing CRISPR-related biological research services, tools, and reagents. The Ccampany produces all research tools and reagents under […]

Beckley Psytech, a company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has appointed Andy Page as its Chief Operating Officer. Page brings over 25 years’ experience working within global pharmaceutical and medtech organisations in strategic and operation roles. He started his career at SmithKline Beecham before joining Johnson & Johnson at Janssen […]

Swedish biotech company Salipro Biotech has announced that the European Patent Office has issued the European Patent No. 3463303, titled “Saposin lipoprotein particles and libraries from crude membranes”. The patent covers the company’s novel method of direct extraction of membrane proteins (DirectMXTM) from cells or crude membranes to enable drug development for challenging drug targets, […]